Lunai Bioworks Inc. Logo

Lunai Bioworks Inc. (LNAI)

NASDAQ

Currency in USD
0.2360
-0.02 (-6.72%)

Closed

Oct 28, 2026

Day's Range

0.2020
0.2500

52 wk Range

0.2020
13.28

Profile - LNAI - Lunai Bioworks Inc.

Profile

Mic Code

XNCM

Sector

Healthcare

Industry

Biotechnology

Employees

12


Lunai Bioworks Inc. is a pre-clinical biotechnology company focused on developing medicines, diagnostics, and biodefense solutions. The company works across cancer, infectious disease, and precision medicine through genetically modified cell and immune-therapy platforms, including allogeneic dendritic cell vaccine programs for solid tumors such as pancreatic and breast cancers. Its business also includes AI-enabled diagnostics and multi-omics analytics designed to support early cancer detection and recurrence monitoring by identifying individual biomarkers, including in asymptomatic patients. Through its operating segments, Lunai Bioworks combines computational biology, experimental biology, and data-driven platforms to advance therapeutic discovery and improve clinical decision-making. The company is headquartered in Los Angeles, California, and serves healthcare-related markets in the United States and the Netherlands.

Profile Details

Type

Common Stock

Address

3400 Cottage Way

City

Sacramento

State

CA

Zip

95825

Country

United States

Phone

(424) 222-9301

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.